Award notice, first published as presolicitation
Influenza Vaccine 2025-2026 Flu Season Awarded Line Item 10
36E79724R0031
Department of Veterans Affairs, Nac Pharmaceuticals. Pharmaceutical Preparation Manufacturing.
Awarded
$0.00 obligated so far on USAspending
Get the next one like this from Department of Veterans Affairs by email, the day it is posted.Find my opportunities
This one was awarded in 2024
9 like it are open now in pharmaceutical preparation manufacturing
- Sacubitril/Valsartan Tablets (VA-27-00014055)
Department of Veterans Affairs, Nac Pharmaceuticals
PresolicitationNAICS 325412Anywhere in the US36E79727R0007Closes in 2 daysNov 3 - Methylphenidate ER
Defense Logistics Agency, DLA Troop Support
SolicitationNAICS 325412Anywhere in the USSPE2D226R0013Closes in 5 daysNov 6 - FY27 Lenalidomide BPA
Department of Veterans Affairs, 262-Network Contract Office 22
Sources soughtNAICS 325412Anywhere in the US36C26227Q0083Closes in 11 daysNov 12
Description
As published on SAM.gov with the solicitation of September 23, 2024.
N/A
The contract, on USAspending
Federal procurement data the awarding office reported to FPDS, matched to this solicitation by its number.
- Recipient
- Sanofi Vaccines US Inc.
- UEI
- NCXBGGQ8YTU9
- CAGE
- 7V915
- Vendor location
- Swiftwater, PA
- Contract
- 36E79725D0005
- Obligated
- $0.00, potential $113,671
- Actions
- 4 between November 20, 2024 and February 9, 2026
- Competition
- Full and Open Competition, 3 offers received
- Set-aside reported
- No Set Aside Used.
- Described as
- New Award for the Influenza Virus Vaccine for the 2025-2026 Flu Season with Sanofi Pasteur INC. the Period of Performance Is 03/15/2025 - 03/14/2026.
- Match
- solicitation number 36E79724R0031 equals the FPDS solicitation identifier; same awarding office 36E797 (high confidence)
- Record
- USAspending award page
- Recipient
- Seqirus USA Inc.
- UEI
- N6U7P2B9VHS5
- CAGE
- 530P3
- Vendor location
- Summit, NJ
- Contract
- 36E79725D0006
- Obligated
- $0.00, potential $51,637,946
- Actions
- 3 between November 20, 2024 and August 28, 2025
- Competition
- Full and Open Competition, 3 offers received
- Set-aside reported
- No Set Aside Used.
- Described as
- New Award for the Influenza Virus Vaccine for the 2025-2026 Flu Season with Seqirus USA INC. the Period of Performance Is 03/15/2025 - 03/14/2026.
- Match
- award number 36E79725D0006 equals the contract number; same awarding office 36E797 (high confidence)
- Record
- USAspending award page
Publications
Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.
September 11, 2024
Presolicitation
Influenza Virus Vaccine (2025-2026 Flu Season)
Due October 2, 2024 at 3:30 PM EDT. SAM.gov, notice 7a7a34dc648140e2bcb1693cc7a463ab
September 23, 2024
Solicitation, originally presolicitation
Influenza Virus Vaccine (2025-2026 Flu Season)
Due October 8, 2024 at 3:30 PM EDT. SAM.gov, notice b3b8ecc590bf429c9ebe9672b17b45d5
November 20, 2024
Award notice
Influenza Virus Vaccine 2025-2026 Flu Season; Awarded Line Items 1, 2, 3, 4, 5, 6, 7, 8, 9, 11, and 12
Awarded to Seqirus USA Inc. Summit 07901 Jib for $51,637,946. SAM.gov, notice 123f802ca5024198be3510423842d9ba
November 20, 2024
Award notice
Awarded to Sanofi Pasteur Inc. Swiftwater 18370 for $113,671. SAM.gov, notice f6cf1f3f0a5043b1abcedb60f9f24854
Points of contact
- Deborah Fassl, Contract SpecialistDeborah.Fassl@va.gov708-786-5894